Prodia Widyahusada Tbk PT (PRDA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Prodia Widyahusada Tbk PT (PRDA) has a cash flow conversion efficiency ratio of 0.073x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp169.15 Billion ≈ $9.91 Million USD) by net assets (Rp2.31 Trillion ≈ $135.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Prodia Widyahusada Tbk PT - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Prodia Widyahusada Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PRDA total liabilities for a breakdown of total debt and financial obligations.
Prodia Widyahusada Tbk PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Prodia Widyahusada Tbk PT ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Perfect Corp.
NYSE:PERF
|
0.018x |
|
ChargePoint Holdings Inc
NYSE:CHPT
|
-0.586x |
|
Peter Warren Automotive Holdings Ltd
AU:PWR
|
0.106x |
|
TUDOR GOLD CORP. O.N.
F:H56
|
N/A |
|
LOT VACUUM Co. Ltd
KQ:083310
|
-0.011x |
|
Southern Palladium Ltd
AU:SPD
|
-0.026x |
|
ROKISKIO SURIS PC EO 029
F:YTV
|
N/A |
|
Mahkota Group Tbk PT
JK:MGRO
|
-0.440x |
Annual Cash Flow Conversion Efficiency for Prodia Widyahusada Tbk PT (2013–2024)
The table below shows the annual cash flow conversion efficiency of Prodia Widyahusada Tbk PT from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Prodia Widyahusada Tbk PT market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp2.48 Trillion ≈ $145.59 Million |
Rp476.64 Billion ≈ $27.93 Million |
0.192x | +10.10% |
| 2023-12-31 | Rp2.36 Trillion ≈ $138.32 Million |
Rp411.29 Billion ≈ $24.10 Million |
0.174x | -18.94% |
| 2022-12-31 | Rp2.31 Trillion ≈ $135.42 Million |
Rp496.73 Billion ≈ $29.11 Million |
0.215x | -37.72% |
| 2021-12-31 | Rp2.25 Trillion ≈ $131.98 Million |
Rp777.27 Billion ≈ $45.54 Million |
0.345x | +41.99% |
| 2020-12-31 | Rp1.79 Trillion ≈ $104.79 Million |
Rp434.63 Billion ≈ $25.47 Million |
0.243x | +18.00% |
| 2019-12-31 | Rp1.66 Trillion ≈ $97.25 Million |
Rp341.82 Billion ≈ $20.03 Million |
0.206x | +34.16% |
| 2018-12-31 | Rp1.56 Trillion ≈ $91.54 Million |
Rp239.83 Billion ≈ $14.05 Million |
0.154x | +123.89% |
| 2017-12-31 | Rp1.36 Trillion ≈ $79.87 Million |
Rp93.47 Billion ≈ $5.48 Million |
0.069x | -27.13% |
| 2016-12-31 | Rp1.27 Trillion ≈ $74.26 Million |
Rp119.25 Billion ≈ $6.99 Million |
0.094x | -92.36% |
| 2015-12-31 | Rp126.33 Billion ≈ $7.40 Million |
Rp155.61 Billion ≈ $9.12 Million |
1.232x | +56.52% |
| 2014-12-31 | Rp134.25 Billion ≈ $7.87 Million |
Rp105.66 Billion ≈ $6.19 Million |
0.787x | -15.91% |
| 2013-12-31 | Rp88.32 Billion ≈ $5.18 Million |
Rp82.66 Billion ≈ $4.84 Million |
0.936x | -- |
About Prodia Widyahusada Tbk PT
PT Prodia Widyahusada Tbk provides clinical laboratory services primarily in Indonesia. The company offers laboratory, genomic, non-laboratory, and panel test services. It also operates Prodia specialty clinics; and offers vaccination, doctor consultation, and home services. It serves to individuals, doctors, and corporate and partnerships. The company was founded in 1973 and is headquartered in … Read more